01931 IVD MEDICAL
Trading Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 2.40X | Oper Margin | 14.4% |
|---|---|---|---|
| LT Debt/Equity | N/A | Net Margin | 8.2% |
| Total Debt/Equity | 19.7% | Return on Equity | 7.0% |
| Price/Book | 4.56X | Return on Assets | 4.7% |
| (HKD 11.080) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 276.96 | 262.50 | 235.45 | 213.48 | 188.37 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +5.5 | +11.5 | +10.3 | +13.3 | -38.7 |
| Earnings Per Share (HKD) | 0.185 | 0.194 | 0.175 | 0.161 | 0.142 |
| Earnings Per Share Growth (%) | -4.6 | +10.9 | +8.5 | +14.0 | -47.8 |
| Dividend Per Share (HKD) | No dividend | 0.092 | 0.083 | 0.079 | 0.053 |
| P/E* (X) | 59.83 | 57.05 | 63.28 | 68.65 | 78.25 |
| Yield (%) | N/A | 0.83 | 0.75 | 0.72 | 0.48 |
| Dividend Share (%) | N/A | 47.27 | 47.34 | 49.19 | 37.29 |
| Book NAV (HKD) | 2.430 | 2.722 | 2.610 | 2.693 | 2.539 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-07 21:40:22
Latest Result
| (RMBMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
| Cover Period (mths) | 6 | 6 | NA | 6 |
|---|---|---|---|---|
| Turnover | 1,270 | 1,353 | -6.1 | 1,377 |
| Operating Result | 77.876 | 184.369 | -57.8 | 175.607 |
| Associates | -6.032 | -3.919 | +53.9 | -12.792 |
| Profit Before Taxation | 71.844 | 180.491 | -60.2 | 162.909 |
| Taxation | 33.518 | 52.925 | -36.7 | 58.907 |
| Profit /( Loss) After Taxation | 38.326 | 127.566 | -70.0 | 104.002 |
| Minority Interests | -0.793 | 2.278 | -134.8 | 0.993 |
| Net Profit | 39.119 | 125.288 | -68.8 | 103.009 |
| Earnings Per Share () | 0.0264 | 0.0996 | -73.5 | 0.0822 |
| Dividend Per Share () | 0.0000 | 0.0000 | N/A | 0.0297 |
| Announcement Date | 2025-08-29 | 2024-08-28 | NA | 2023-08-18 |
* Annualised
Last Update Time: 2025-09-07 21:40:27
